Unlike injectables, it's a daily pill, offering a convenient option for needle-free weight loss support
Food and Drug Administration has approved semaglutide (Wegovy) injection for chronic weight management in adults with obesity or overweight with at least one weight-related condition (such as high blood pressure, type 2 diabetes, or high cholesterol)
Patients with obesity who are at risk for low muscle mass, affecting both physical and metabolic function, may benefit from treatments that maximize fat mass reduction while preserving skeletal muscle, said Heymsfield, who is an LSU Boyd Professor and director of the Metabolism and Body Composition Laboratory
What to Expect During Semaglutide Treatment Your semaglutide journey begins with the lowest effective dose, gradually increasing based on your body's response
Using Ozempic for this purpose would be off-label, unsupported by NICE guidance, and potentially expose patients to medication risks without proven benefit
